Saudi-based healthcare technology company Aumet has raised $7 million in a Pre-Series A
funding round, attracting investments from venture capitalists and private equity firms from
around the world.
Among the investors who participated in this round are healthcare investors and
pharmaceutical conglomerates such as AAIC, the healthcare-focused Tokyo-based VC , the
Swiss PE firm AIJ Holdings, Hamad Ali Sagri family office, Tijah Holdings, the firm founded by the
co-founders of Salehiya Trading, one of the top pharmaceutical distributors in Saudi Arabia,
including Cigalah Group, the largest pharmaceutical suppliers in Saudi market headed by Mr.
Yasser Naghi, and Shorooq Partners, the leading tech investor in MENAP and an early backer of
Aumet in pre-seed and seed stages has also participated in this round.
Aumet, MENA’s largest AI-enabled B2B healthcare platform, uses predictive analytics to
forecast the procurement of products for pharmacies, resulting in significant cost savings and
greater efficiencies in the supply chain of the 10,000+ pharmacies who use their solution across
three core markets: Saudi Arabia, Jordan and Egypt.
“We are thrilled to have the support of such esteemed investors who share our vision of
transforming the healthcare industry through technology,” said CEO Yahya Aqel. “With this
round of funding, we will continue to innovate and improve our platform, providing more value
to our customers and helping to improve the overall healthcare experience for all.”
The company, led by CEO Yahya Aqel, a serial entrepreneur with two successful exits, and Adel
Haddad, Yahya Al Najjar, Ahmad Smadi, each with extensive experience in their respective
domains, plans to further develop its AI capabilities and expand its reach to more pharmacies
around the world, providing greater access to affordable healthcare products for consumers to
achieve its brand promise of “Securing the lives of a billion of people by digitalizing the
medicine and medical procurement cycle globally”.